Although the exact mechanism by which the two classes of inhibitors interact to induce necrosis of BRAFV600E melanoma cells remains to be defined, a number of factors including RIPK1, RIPK3, and generation of ROS do not appear to have a major role. Here, RIPK3 is linked to melanoma.